WebHighlights. We have created a cell line that produces an anti-HIV antibody called Clone 3. We have demonstrated that Clone 3 neutralizes all clades and groups of HIV isolates. We have identified that Clone 3 targets HIV … WebBioClonetics Immunotherapeutics is a biotechnology company with a proprietary methodology and expertise for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with ...
Patents Assigned to BioClonetics - Justia Patents Search
WebClone (B-cell) The process of immunological B-cell maturation involves transformation from an undifferentiated B cell to one that secretes antibodies with particular specificity. [1] … WebBioClonetics' antibody-based immunotherapeutics platform can be utilized across both human and animal infectious-disease applications. For example, the technology can be used to produce treatment for … cyklop cerclage
Enzolytics, Inc., Charles S. Cotropia, Monoclonal …
WebNov 13, 2024 · BioClonetics Immunotherapeutics, Inc. is a Dallas Texas biotech company with proprietary technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases including HIV ... WebBioClonetics Immunotherapeutics is a biotechnology company with a proprietary methodology and expertise for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. BioClonetics Immunotherapeutics is a biotechnology company with a … BioClonetics’ technological methodologies have developed an effective, strong and … - Cano et al. cited the BioClonetics publications on (Clone 3) mAb, noting … BioClonetics’ technology addresses the HIV/AIDS pandemic with a proprietary … - Pendintg Patent coverage of small molecules (mini-peptides) for … Charles Cotropia, CEO, Juris Doctorate Degree Cornell Univ., B.S. Aerospace … Curing HIV – The BioClonetics Commitment Incorporating learning from leading … The Clone 3 Antibody secreted by the parent cell line created by the company … Projected Earnings from the BioClonetics’ passive immunotherapy have been … PUBLICATIONS SUPPORTING OUR TECHNOLOGY. Cheung, G., Cotropia, … WebSep 16, 2024 · BioClonetics is in the final stage of development of a parent monoclonal antibody ("mAbs") (designated as Clone 3), which is non-toxic and has shown in initial … cyklop barn mares